NodThera attracts $55m
UK and U.S.-based NodThera, a developer of medicines that treat diseases driven by chronic inflammation, has raised $55 million in funding.
UK and U.S.-based NodThera, a developer of medicines that treat diseases driven by chronic inflammation, has raised $55 million in funding.
Copyright PEI Media
Not for publication, email or dissemination